118 related articles for article (PubMed ID: 38579362)
1. Retraction notice to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78].
Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
EBioMedicine; 2024 May; 103():105105. PubMed ID: 38579362
[No Abstract] [Full Text] [Related]
2. Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772].
Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
EBioMedicine; 2024 May; 103():105106. PubMed ID: 38579361
[No Abstract] [Full Text] [Related]
3. Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78].
Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
EBioMedicine; 2020 May; 55():102772. PubMed ID: 32416443
[No Abstract] [Full Text] [Related]
4. MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway.
Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
EBioMedicine; 2019 Aug; 46():66-78. PubMed ID: 31383552
[TBL] [Abstract][Full Text] [Related]
5. Retraction notice to "LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190].
Hua X; Liu Z; Zhou M; Tian Y; Zhao PP; Pan WH; Li CX; Huang XX; Liao ZX; Xian Q; Chen B; Hu Y; Leng L; Fang XW; Yu LN
EBioMedicine; 2021 Oct; 72():103665. PubMed ID: 34717838
[No Abstract] [Full Text] [Related]
6. Retraction Notice to 'MiR-15a-5p targets FOSL1 to inhibit proliferation and promote apoptosis of keratinocytes via MAPK/ERK pathway' [J Tissue Viability 30/4 (2021) 544-551].
Meng J; Chen FR; Yan WJ; Lin YK
J Tissue Viability; 2022 Nov; 31(4):808. PubMed ID: 35981908
[No Abstract] [Full Text] [Related]
7. Retraction notice to "LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN" [EBioMedicine 44 (2019) 298-310].
Li W; Huang K; Wen F; Cui G; Guo H; He Z; Zhao S
EBioMedicine; 2024 Jun; 104():105192. PubMed ID: 38833840
[No Abstract] [Full Text] [Related]
8. MicroRNA-148a regulates the MAPK/ERK signaling pathway and suppresses the development of esophagus squamous cell carcinoma via targeting MAP3K9.
Zhang BX; Yu T; Yu Z; Yang XG
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6497-6504. PubMed ID: 31378889
[TBL] [Abstract][Full Text] [Related]
9. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
[TBL] [Abstract][Full Text] [Related]
10. Retraction notice to "Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2" [Archives of Oral Biology 130C (2021) 105219].
Wang X; Zhang Y; Zhang S; Duan L
Arch Oral Biol; 2022 Sep; 141():105494. PubMed ID: 35810495
[No Abstract] [Full Text] [Related]
11. Retraction notice to "Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-FOXO3a pathway" [Life Sci. 257 (2020) 118104].
Wang Y; Xie Z; Lu H
Life Sci; 2022 Nov; 308():120813. PubMed ID: 35945078
[No Abstract] [Full Text] [Related]
12. Retraction notice to "MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC)" [Biomed. Pharmacother. 76 (2015) 82-93].
Mao Y; Liu J; Zhang D; Li B
Biomed Pharmacother; 2024 Feb; 171():116189. PubMed ID: 38296731
[No Abstract] [Full Text] [Related]
13. Retraction notice to 'Neurotensin contributes to pediatric intestinal failure-associated liver disease via regulating intestinal bile acids uptake': [EBioMedicine 35 (2018) 133-141].
Xiao Y; Yan W; Lu Y; Zhou K; Cai W
EBioMedicine; 2020 Jul; 57():102927. PubMed ID: 32711918
[No Abstract] [Full Text] [Related]
14. DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway.
Ge Y; Fan X; Huang X; Weygant N; Xiao Z; Yan R; Liu H; Liu J; An G; Yao J
Mol Cancer Res; 2021 Dec; 19(12):1980-1991. PubMed ID: 34610960
[TBL] [Abstract][Full Text] [Related]
15. Retraction notice to "Reciprocal regulation of miR-1254 and c-Myc in oral squamous cell carcinoma suppresses EMT-mediated metastasis and tumor-initiating properties through MAPK signaling" [Biochem. Biophys. Res. Commun. 484 (4) (2017) 801-807].
Lu M; Chen WH; Wang CY; Mao CQ; Wang J
Biochem Biophys Res Commun; 2018 Mar; 497(4):1186. PubMed ID: 29530246
[No Abstract] [Full Text] [Related]
16. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma.
Hiyoshi Y; Kamohara H; Karashima R; Sato N; Imamura Y; Nagai Y; Yoshida N; Toyama E; Hayashi N; Watanabe M; Baba H
Clin Cancer Res; 2009 Mar; 15(6):1915-22. PubMed ID: 19276261
[TBL] [Abstract][Full Text] [Related]
17. EPB41L5 promotes EMT through the ERK/p38 MAPK signaling pathway in esophageal squamous cell carcinoma.
Bao S; Ji Z; Shi M; Liu X
Pathol Res Pract; 2021 Dec; 228():153682. PubMed ID: 34784520
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-181a-5p prevents the progression of esophageal squamous cell carcinoma
Wang M; Huang C; Gao W; Zhu Y; Zhang F; Li Z; Tian Z
Aging (Albany NY); 2022 Apr; 14(8):3540-3553. PubMed ID: 35468097
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
[TBL] [Abstract][Full Text] [Related]
20. Retraction: Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1.
Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36354012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
